Mizuho raised the firm’s price target on Guardant Health (GH) to $135 from $120 and keeps an Outperform rating on the shares. The firm updated models in the medical devices and diagnostics group.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GH:
- Guardant Health price target raised to $130 from $100 at TD Cowen
- RBLX, META, GH, IONS: Cathie Wood Loads Up on Roblox, Trims Meta and Biotech Stocks
- Guardant Health management to meet virtually with BTIG
- TEM, KDK, PSNL: Cathie Wood Loads Up on AI Health Tech, Trims SHOP & ROKU
- Guardant Health price target raised to $115 from $85 at Guggenheim